China Gastrointestinal Stromal Tumor (GIST) Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Gastrointestinal Stromal Tumor (GIST) Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Gastrointestinal Stromal Tumor (GIST) Drug market. Detailed analysis of key players, along with key growth strategies adopted by Gastrointestinal Stromal Tumor (GIST) Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astex Pharmaceuticals, Inc

    • Array BioPharma Inc

    • Omeros Corporation

    • Arog Pharmaceuticals, Inc

    • Novartis AG

    • F Hoffmann-La Roche Ltd

    • Ariad Pharmaceuticals, Inc

    • Deciphera Pharmaceuticals, LLC

    • Boston Biomedical, Inc

    • Nerviano Medical Sciences Srl

    • Immunicum AB

    • Jiangsu Hengrui Medicine Co, Ltd

    • Kolltan Pharmaceuticals, Inc

    • Natco Pharma Limited

    • Blueprint Medicines Corporation

    • Horizon Pharma Plc

    • Calithera Biosciences, Inc

    • Chipscreen Biosciences Ltd

    By Type:

    • Amcasertib

    • Anagrelide hydrochloride CR

    • APG-1351

    • Binimetinib

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Stromal Tumor (GIST) Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Amcasertib from 2016 to 2027

    • 1.3.2 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Anagrelide hydrochloride CR from 2016 to 2027

    • 1.3.3 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of APG-1351 from 2016 to 2027

    • 1.3.4 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Binimetinib from 2016 to 2027

    • 1.3.5 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Clinic from 2016 to 2027

    • 1.4.2 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.3 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Gastrointestinal Stromal Tumor (GIST) Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gastrointestinal Stromal Tumor (GIST) Drug by Major Types

    • 3.4.1 Market Size and Growth Rate of Amcasertib

    • 3.4.2 Market Size and Growth Rate of Anagrelide hydrochloride CR

    • 3.4.3 Market Size and Growth Rate of APG-1351

    • 3.4.4 Market Size and Growth Rate of Binimetinib

    • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Gastrointestinal Stromal Tumor (GIST) Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gastrointestinal Stromal Tumor (GIST) Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Gastrointestinal Stromal Tumor (GIST) Drug in Clinic

    • 4.4.2 Market Size and Growth Rate of Gastrointestinal Stromal Tumor (GIST) Drug in Hospital

    • 4.4.3 Market Size and Growth Rate of Gastrointestinal Stromal Tumor (GIST) Drug in Others

    5 Market Analysis by Regions

    • 5.1 China Gastrointestinal Stromal Tumor (GIST) Drug Production Analysis by Regions

    • 5.2 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis

    • 6.1 North China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major Types

    • 6.2 North China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major End-Users

    7 Central China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis

    • 7.1 Central China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major Types

    • 7.2 Central China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major End-Users

    8 South China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis

    • 8.1 South China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major Types

    • 8.2 South China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major End-Users

    9 East China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis

    • 9.1 East China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major Types

    • 9.2 East China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major End-Users

    10 Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis

    • 10.1 Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major Types

    • 10.2 Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major End-Users

    11 Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis

    • 11.1 Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major Types

    • 11.2 Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major End-Users

    12 Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis

    • 12.1 Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major Types

    • 12.2 Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Astex Pharmaceuticals, Inc

      • 13.1.1 Astex Pharmaceuticals, Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Array BioPharma Inc

      • 13.2.1 Array BioPharma Inc Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Omeros Corporation

      • 13.3.1 Omeros Corporation Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Arog Pharmaceuticals, Inc

      • 13.4.1 Arog Pharmaceuticals, Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Novartis AG

      • 13.5.1 Novartis AG Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 F Hoffmann-La Roche Ltd

      • 13.6.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Ariad Pharmaceuticals, Inc

      • 13.7.1 Ariad Pharmaceuticals, Inc Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Deciphera Pharmaceuticals, LLC

      • 13.8.1 Deciphera Pharmaceuticals, LLC Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Boston Biomedical, Inc

      • 13.9.1 Boston Biomedical, Inc Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Nerviano Medical Sciences Srl

      • 13.10.1 Nerviano Medical Sciences Srl Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Immunicum AB

      • 13.11.1 Immunicum AB Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Jiangsu Hengrui Medicine Co, Ltd

      • 13.12.1 Jiangsu Hengrui Medicine Co, Ltd Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Kolltan Pharmaceuticals, Inc

      • 13.13.1 Kolltan Pharmaceuticals, Inc Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Natco Pharma Limited

      • 13.14.1 Natco Pharma Limited Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 Blueprint Medicines Corporation

      • 13.15.1 Blueprint Medicines Corporation Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    • 13.16 Horizon Pharma Plc

      • 13.16.1 Horizon Pharma Plc Company Profile and Recent Development

      • 13.16.2 Market Performance

      • 13.16.3 Product and Service Introduction

    • 13.17 Calithera Biosciences, Inc

      • 13.17.1 Calithera Biosciences, Inc Company Profile and Recent Development

      • 13.17.2 Market Performance

      • 13.17.3 Product and Service Introduction

    • 13.18 Chipscreen Biosciences Ltd

      • 13.18.1 Chipscreen Biosciences Ltd Company Profile and Recent Development

      • 13.18.2 Market Performance

      • 13.18.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Amcasertib from 2016 to 2027

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Anagrelide hydrochloride CR from 2016 to 2027

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of APG-1351 from 2016 to 2027

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Binimetinib from 2016 to 2027

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Clinic from 2016 to 2027

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Gastrointestinal Stromal Tumor (GIST) Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Gastrointestinal Stromal Tumor (GIST) Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Gastrointestinal Stromal Tumor (GIST) Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Amcasertib

    • Figure Market Size and Growth Rate of Anagrelide hydrochloride CR

    • Figure Market Size and Growth Rate of APG-1351

    • Figure Market Size and Growth Rate of Binimetinib

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Gastrointestinal Stromal Tumor (GIST) Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Others

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Regions

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Regions in 2016

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Regions in 2021

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Regions in 2027

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Regions

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Regions in 2016

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Regions in 2021

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Regions in 2027

    • Table North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Types from 2016 to 2027

    • Table North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types from 2016 to 2027

    • Figure North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2016

    • Figure North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2021

    • Figure North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2027

    • Table North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by End-Users from 2016 to 2027

    • Table North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2016

    • Figure North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2021

    • Figure North China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2027

    • Table Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Types from 2016 to 2027

    • Table Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types from 2016 to 2027

    • Figure Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2016

    • Figure Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2021

    • Figure Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2027

    • Table Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by End-Users from 2016 to 2027

    • Table Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2016

    • Figure Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2021

    • Figure Central China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2027

    • Table South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Types from 2016 to 2027

    • Table South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types from 2016 to 2027

    • Figure South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2016

    • Figure South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2021

    • Figure South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2027

    • Table South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by End-Users from 2016 to 2027

    • Table South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2016

    • Figure South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2021

    • Figure South China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2027

    • Table East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Types from 2016 to 2027

    • Table East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types from 2016 to 2027

    • Figure East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2016

    • Figure East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2021

    • Figure East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2027

    • Table East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by End-Users from 2016 to 2027

    • Table East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2016

    • Figure East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2021

    • Figure East China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2027

    • Table Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Types from 2016 to 2027

    • Table Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2016

    • Figure Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2021

    • Figure Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2027

    • Table Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2016

    • Figure Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2021

    • Figure Northeast China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2027

    • Table Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Types from 2016 to 2027

    • Table Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2016

    • Figure Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2021

    • Figure Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2027

    • Table Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by End-Users from 2016 to 2027

    • Table Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2016

    • Figure Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2021

    • Figure Southwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2027

    • Table Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Types from 2016 to 2027

    • Table Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2016

    • Figure Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2021

    • Figure Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by Types in 2027

    • Table Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption by End-Users from 2016 to 2027

    • Table Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2016

    • Figure Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2021

    • Figure Northwest China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Astex Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astex Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Astex Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Astex Pharmaceuticals, Inc

    • Table Product and Service Introduction of Astex Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Array BioPharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Array BioPharma Inc

    • Figure Sales and Growth Rate Analysis of Array BioPharma Inc

    • Figure Revenue and Market Share Analysis of Array BioPharma Inc

    • Table Product and Service Introduction of Array BioPharma Inc

    • Table Company Profile and Development Status of Omeros Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omeros Corporation

    • Figure Sales and Growth Rate Analysis of Omeros Corporation

    • Figure Revenue and Market Share Analysis of Omeros Corporation

    • Table Product and Service Introduction of Omeros Corporation

    • Table Company Profile and Development Status of Arog Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arog Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Arog Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Arog Pharmaceuticals, Inc

    • Table Product and Service Introduction of Arog Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Ariad Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ariad Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Ariad Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Ariad Pharmaceuticals, Inc

    • Table Product and Service Introduction of Ariad Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Deciphera Pharmaceuticals, LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Deciphera Pharmaceuticals, LLC

    • Figure Sales and Growth Rate Analysis of Deciphera Pharmaceuticals, LLC

    • Figure Revenue and Market Share Analysis of Deciphera Pharmaceuticals, LLC

    • Table Product and Service Introduction of Deciphera Pharmaceuticals, LLC

    • Table Company Profile and Development Status of Boston Biomedical, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Biomedical, Inc

    • Figure Sales and Growth Rate Analysis of Boston Biomedical, Inc

    • Figure Revenue and Market Share Analysis of Boston Biomedical, Inc

    • Table Product and Service Introduction of Boston Biomedical, Inc

    • Table Company Profile and Development Status of Nerviano Medical Sciences Srl

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nerviano Medical Sciences Srl

    • Figure Sales and Growth Rate Analysis of Nerviano Medical Sciences Srl

    • Figure Revenue and Market Share Analysis of Nerviano Medical Sciences Srl

    • Table Product and Service Introduction of Nerviano Medical Sciences Srl

    • Table Company Profile and Development Status of Immunicum AB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunicum AB

    • Figure Sales and Growth Rate Analysis of Immunicum AB

    • Figure Revenue and Market Share Analysis of Immunicum AB

    • Table Product and Service Introduction of Immunicum AB

    • Table Company Profile and Development Status of Jiangsu Hengrui Medicine Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Hengrui Medicine Co, Ltd

    • Figure Sales and Growth Rate Analysis of Jiangsu Hengrui Medicine Co, Ltd

    • Figure Revenue and Market Share Analysis of Jiangsu Hengrui Medicine Co, Ltd

    • Table Product and Service Introduction of Jiangsu Hengrui Medicine Co, Ltd

    • Table Company Profile and Development Status of Kolltan Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kolltan Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Kolltan Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Kolltan Pharmaceuticals, Inc

    • Table Product and Service Introduction of Kolltan Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Natco Pharma Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Natco Pharma Limited

    • Figure Sales and Growth Rate Analysis of Natco Pharma Limited

    • Figure Revenue and Market Share Analysis of Natco Pharma Limited

    • Table Product and Service Introduction of Natco Pharma Limited

    • Table Company Profile and Development Status of Blueprint Medicines Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Blueprint Medicines Corporation

    • Figure Sales and Growth Rate Analysis of Blueprint Medicines Corporation

    • Figure Revenue and Market Share Analysis of Blueprint Medicines Corporation

    • Table Product and Service Introduction of Blueprint Medicines Corporation

    • Table Company Profile and Development Status of Horizon Pharma Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Pharma Plc

    • Figure Sales and Growth Rate Analysis of Horizon Pharma Plc

    • Figure Revenue and Market Share Analysis of Horizon Pharma Plc

    • Table Product and Service Introduction of Horizon Pharma Plc

    • Table Company Profile and Development Status of Calithera Biosciences, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calithera Biosciences, Inc

    • Figure Sales and Growth Rate Analysis of Calithera Biosciences, Inc

    • Figure Revenue and Market Share Analysis of Calithera Biosciences, Inc

    • Table Product and Service Introduction of Calithera Biosciences, Inc

    • Table Company Profile and Development Status of Chipscreen Biosciences Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences Ltd

    • Figure Sales and Growth Rate Analysis of Chipscreen Biosciences Ltd

    • Figure Revenue and Market Share Analysis of Chipscreen Biosciences Ltd

    • Table Product and Service Introduction of Chipscreen Biosciences Ltd


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.